New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11953332.
- Also identified by PMC identifier 1867683.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although new salicylates are now available for the treatment of ulcerative colitis, sulphasazaline still has an important therapeutic role. The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission. New steroids are a real alternative to traditional steroids in active ulcerative colitis and Crohn's disease.
Medical subject headings
- Colitis, Ulcerative
- Crohn Disease
- Glucocorticoids
- Salicylates